358 related articles for article (PubMed ID: 25640159)
1. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.
Lehrke M; Kahles F; Makowska A; Tilstam PV; Diebold S; Marx J; Stöhr R; Hess K; Endorf EB; Bruemmer D; Marx N; Findeisen HM
J Mol Cell Cardiol; 2015 Apr; 81():23-33. PubMed ID: 25640159
[TBL] [Abstract][Full Text] [Related]
2. PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways.
Kwak HJ; Park KM; Choi HE; Chung KS; Lim HJ; Park HY
Cell Signal; 2008 May; 20(5):803-14. PubMed ID: 18276108
[TBL] [Abstract][Full Text] [Related]
3. Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation.
Kato Y; Yokoyama U; Yanai C; Ishige R; Kurotaki D; Umemura M; Fujita T; Kubota T; Okumura S; Sata M; Tamura T; Ishikawa Y
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2617-25. PubMed ID: 26427796
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
Growcott EJ; Spink KG; Ren X; Afzal S; Banner KH; Wharton J
Respir Res; 2006 Jan; 7(1):9. PubMed ID: 16423283
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
[TBL] [Abstract][Full Text] [Related]
6. Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
Daniel JM; Prock A; Dutzmann J; Sonnenschein K; Thum T; Bauersachs J; Sedding DG
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):317-27. PubMed ID: 26663397
[TBL] [Abstract][Full Text] [Related]
7. Effects of roflumilast, a phosphodiesterase-4 inhibitor, on hypoxia- and monocrotaline-induced pulmonary hypertension in rats.
Izikki M; Raffestin B; Klar J; Hatzelmann A; Marx D; Tenor H; Zadigue P; Adnot S; Eddahibi S
J Pharmacol Exp Ther; 2009 Jul; 330(1):54-62. PubMed ID: 19386793
[TBL] [Abstract][Full Text] [Related]
8. Reduction of endoplasmic reticulum stress inhibits neointima formation after vascular injury.
Ishimura S; Furuhashi M; Mita T; Fuseya T; Watanabe Y; Hoshina K; Kokubu N; Inoue K; Yoshida H; Miura T
Sci Rep; 2014 Nov; 4():6943. PubMed ID: 25373918
[TBL] [Abstract][Full Text] [Related]
9. Direct Inhibitory Effect of the PDE4 Inhibitor Roflumilast on Neutrophil Migration in Chronic Obstructive Pulmonary Disease.
Dunne AE; Kawamatawong T; Fenwick PS; Davies CM; Tullett H; Barnes PJ; Donnelly LE
Am J Respir Cell Mol Biol; 2019 Apr; 60(4):445-453. PubMed ID: 30395484
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between PKA-Cβ and p65 mediates synergistic induction of PDE4B by roflumilast and NTHi.
Susuki-Miyata S; Miyata M; Lee BC; Xu H; Kai H; Yan C; Li JD
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):E1800-9. PubMed ID: 25831493
[TBL] [Abstract][Full Text] [Related]
11. Salt-Inducible Kinase 3 Promotes Vascular Smooth Muscle Cell Proliferation and Arterial Restenosis by Regulating AKT and PKA-CREB Signaling.
Cai Y; Wang XL; Lu J; Lin X; Dong J; Guzman RJ
Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2431-2451. PubMed ID: 34196217
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro.
Hatzelmann A; Schudt C
J Pharmacol Exp Ther; 2001 Apr; 297(1):267-79. PubMed ID: 11259554
[TBL] [Abstract][Full Text] [Related]
13. The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation.
Konrad FM; Bury A; Schick MA; Ngamsri KC; Reutershan J
PLoS One; 2015; 10(4):e0121725. PubMed ID: 25909327
[TBL] [Abstract][Full Text] [Related]
14. Cleaved high-molecular-weight kininogen inhibits neointima formation following vascular injury.
Daniel JM; Reich F; Dutzmann J; Weisheit S; Teske R; Gündüz D; Bauersachs J; Preissner KT; Sedding DG
Thromb Haemost; 2015 Aug; 114(3):603-13. PubMed ID: 26063414
[TBL] [Abstract][Full Text] [Related]
15. BET bromodomain-containing epigenetic reader proteins regulate vascular smooth muscle cell proliferation and neointima formation.
Dutzmann J; Haertlé M; Daniel JM; Kloss F; Musmann RJ; Kalies K; Knöpp K; Pilowski C; Sirisko M; Sieweke JT; Bauersachs J; Sedding DG; Gegel S
Cardiovasc Res; 2021 Feb; 117(3):850-862. PubMed ID: 32353113
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation.
Lee CW; Lin WN; Lin CC; Luo SF; Wang JS; Pouyssegur J; Yang CM
J Cell Physiol; 2006 Apr; 207(1):174-86. PubMed ID: 16288471
[TBL] [Abstract][Full Text] [Related]
17. Roflumilast inhibits leukocyte-platelet interactions and prevents the prothrombotic functions of polymorphonuclear leukocytes and monocytes.
Totani L; Amore C; Di Santo A; Dell'Elba G; Piccoli A; Martelli N; Tenor H; Beume R; Evangelista V
J Thromb Haemost; 2016 Jan; 14(1):191-204. PubMed ID: 26484898
[TBL] [Abstract][Full Text] [Related]
18. Roflumilast inhibits leukocyte-endothelial cell interactions, expression of adhesion molecules and microvascular permeability.
Sanz MJ; Cortijo J; Taha MA; Cerdá-Nicolás M; Schatton E; Burgbacher B; Klar J; Tenor H; Schudt C; Issekutz AC; Hatzelmann A; Morcillo EJ
Br J Pharmacol; 2007 Oct; 152(4):481-92. PubMed ID: 17704822
[TBL] [Abstract][Full Text] [Related]
19. Roflumilast partially reverses smoke-induced mucociliary dysfunction.
Schmid A; Baumlin N; Ivonnet P; Dennis JS; Campos M; Krick S; Salathe M
Respir Res; 2015 Oct; 16():135. PubMed ID: 26521141
[TBL] [Abstract][Full Text] [Related]
20. Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration.
Yokoyama U; Minamisawa S; Quan H; Akaike T; Jin M; Otsu K; Ulucan C; Wang X; Baljinnyam E; Takaoka M; Sata M; Ishikawa Y
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1547-55. PubMed ID: 18689492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
